InsidersTradesSigma
Explore the complete record of transactions filed by Jensen Klavs F., Director. Director active across 1 companies, notably SQZ Biotechnologies Co. Aggregated, 1 disclosures have been recorded. Total volume traded: €47k. The latest transaction was filed on 25 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Jensen Klavs F. is a Board Member at SQZ Biotechnologies Co. He plays a crucial role in overseeing the company's operations and strategic decision-making. With his experience in corporate governance, he helps ensure that shareholder interests are protected. His commitment to transparency and integrity is fundamental to SQZ Biotechnologies' mission.